Abstract
Mediastinal tumors are rare in children. They encompass a heterogeneous group of benign and malignant conditions where malignant neoplasms predominate. The anatomic location of the tumor narrows down the differential diagnosis, often accompanied by pathognomonic symptomatology, characteristic imaging findings, and elevation of specific tumor markers. Mediastinal tumors may cause symptoms resulting from mass effect. Careful anesthetic assessment for risks and alternatives should be considered. Video assisted thoracoscopic surgery provides a new approach to the diagnosis and resection of these tumors.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Mediastinum
- Lymphoma
- Thymoma
- Lymphangioma
- Teratoma
- Malignant germ cell tumors
- Neuroblastoma
- Anesthesia
- Superior vena cava syndrome
- Thoracoscopy
Introduction
Primary mediastinal tumors are uncommon in the pediatric population. Mediastinal masses in children include a wide spectrum of pathology [1], from congenital lesions such as duplication cysts found incidentally, to lymphomas presenting with respiratory collapse. Sixty-five to 80 % of mediastinal lesions are malignant [2–5]; therefore they should be investigated without delay. About 40 % of mediastinal tumors occur in children younger than 2 years old.
Anatomy
One of the most fundamental surgical knowledge is the understanding of anatomy (Fig. 27.1). The best way to approach mediastinal lesions is to consider them by their location, which will also have implication on the optimal surgical approach. The mediastinum is divided into the anterior, middle and posterior compartments based on the lateral chest radiograph. The anterior mediastinum is located between the sternum and the pericardium. It contains the thymus, lymph nodes and fat; and is the most common site of pediatric mediastinal masses. The middle compartment is the busiest containing multiple vital structures including the heart, the trachea, the mainstem bronchi and their associated lymphatics, and the aortic arch and great vessels. This visceral compartment starts from the pericardium and ends posteriorly with the trachea. The posterior compartment extends from behind the trachea to the vertebral bodies and the paravertebral sulcus. The posterior compartment is home to the descending thoracic aorta, autonomic ganglia and nerves, esophagus, thoracic duct, lymph nodes, and fat. A clear understanding of the type of tissues present in each compartment is the key to the logical consideration of the differential diagnosis. Table 27.1 illustrates the different types of tumors common to each of the compartments.
The age of the patient at presentation is also important in the differential diagnosis. Infants and young children are more likely to present with neuroblastomas, lymphangiomas, teratomas, and congenital anomalies such as bronchopulmonary foregut malformations. Lymphomas and benign neurogenic tumors are more common in teenagers. Table 27.2 outlines the relationship between age and differential diagnosis of mediastinal masses.
Anterior mediastinal tumors account for 44 % of all mediastinal lesions [2], and 80 % of these are malignant. The major anterior mediastinal tumors can be characterized by the four “terrible” T’s, in the order of frequency: T-Cell lymphomas, Teratomas and germ cell tumors, Thymus, and intrathoracic Thyroid. Although a physiologically enlarged thymus is common in children, thymoma and thoracic thyroid are extremely rare in the pediatric population. Cervical lymphatic malformations, commonly known as cystic lymphangiomas or hygromas, can also extend into the superior mediastinum, and rare cases of primary mediastinal lymphangiomas have been reported.
Twenty percent of mediastinal tumors are found in the middle compartment. These are primarily lymphocytic in origin and include Hodgkin’s disease and non-Hodgkin’s lymphomas. The rare cardiac and pericardial tumors are also found in this compartment.
Posterior mediastinal masses account for 36 % of all mediastinal tumors and two thirds of these are malignant [6]. These tumors usually arise from neurogenic structures located in the paravertebral sulcus; they include neuroblastomas, ganglioneuromas and neurofibromas, and are more commonly seen in infants and toddlers. Other sarcomas or primitive neuroectodermal tumors and, rarely, teratomas can also be found in this compartment. Foregut duplications, bronchogenic cysts, pericardial cysts, and extralobar sequestration can be found in both the middle and posterior mediastinum. These are not neoplasms, but they should be considered in the differential diagnosis.
Clinical Presentation and Diagnosis
Clinical Presentation
Mediastinal tumors may be discovered incidentally or present in a wide range of symptomatology, resulting from direct compression, tumor invasion, functional tumor secretion, or paraneoplastic syndrome. Incidental masses found during routine chest radiograph should be investigated without delay, as the incidence of malignancy is high. Mediastinal tumors can present with cadiorespiratory symptoms from direct mass effect. Compression of the trachea or mainstem bronchi can lead to cough, stridor, and dyspnea. Involvement of the superior vena cava (SVC) may lead to the SVC syndrome. Orthopnea and impending respiratory arrest may result from the combination of airway compression, venous obstruction and cardiac dysfunction. Vigilant anesthetic planning is crucial in the management of these patients as discussed in section “Anesthetic consideration for patients with mediastinal tumors”.
In addition to the direct mass effect, patients may have symptoms associated with systemic effects of the disease process. Patients with lymphoma may have fever, night sweats, and weight loss. Myasthenia gravis is seen in thymomas, and virilization may be present in germ cell tumors. Posterior mediastinal lesions can present with neurologic symptoms due to intra-spinal extension, or Horner’s syndrome resulting from the involvement of the cervicothoracic sympathetic ganglia. Paraneoplastic syndromes such as opsoclonus-myoclonus or watery diarrhea induced by vasoactive intestinal peptide are rare modes of presentation for neurogenic tumors (Fig. 27.2).
Investigation
The definitive diagnosis of a mediastinal tumor should start with a thorough history and physical examination. Close attention to respiratory status and presence of lymphadenopathy is essential. The lateral chest radiograph helps to identify the location of the tumor and guides additional laboratory studies. Complete blood count with differential and comprehensive chemistry panel should be obtained. Urinary catecholamines should be sent in patients with a posterior mediastinal mass, and alpha-fetoprotein (AFP) and beta-human chorionic gonadotropin (β-HCG) should be sent if germ cell tumors are suspected.
CT scan of the chest should be the first diagnostic imaging study to provide more detailed characterization of the tumor and its relationship to the surrounding structures. In the present day technology, the examination can be performed in a matter of seconds and will require no or minimal sedation even in an anxious child [7]. Modern MR imaging is often equivalent to CT in the evaluation of mediastinal masses and avoids radiation. It is also the imaging modality of choice to assess spinal involvement in posterior mediastinal neurogenic tumors [7]. M-iodobenzylguanidine (MIBG) scan is a useful nuclear medicine modality in the preoperative staging assessment of suspected neuroblastomas.
Once the specific diagnosis is confirmed, treatment strategies of the mediastinal tumor can be tailored to the disease process. Lymphomas are treated with systemic chemotherapy and radiation, and malignant germ cell tumors will benefit from neoadjuvant chemotherapy. Otherwise, surgical resection is the definitive treatment for most mediastinal pathologies.
Anterior Mediastinal Tumors
Children with anterior mediastinal tumors can pose significant challenges in diagnosis and management. An algorithmic approach with multidisciplinary involvement provides the optimal care for these fragile patients [8]. The pediatric surgeon is often called upon to coordinate care between pediatric oncologist, critical care/intensivist, anesthesiologist, and interventional radiologist; and to decide the best approach to obtain adequate tissue for diagnosis in concert with the pathologist. Once a child presents with a symptomatic anterior mediastinal mass, a careful search of extra-mediastinal involvement is essential. The least invasive and lowest risk procedure should be utilized first [9]. Peripheral blood smear and flow cytometry may be diagnostic of leukemia. Elevated serum AFP will point to yolk-sac germ cell tumors. A mass containing mixed solid/cystic elements and fat on CT scan or MRI will lead to the diagnosis of teratoma. Chest radiograph may reveal pleural effusion, in which case fluid obtained by pleurocentesis can be sent for flow cytometry and cytology. Careful physical examination may reveal cervical lymphadenopathy that can be biopsied under local anesthesia with conscious sedation.
Lymphomas
Malignant lymphoma is the most common mediastinal tumor in children, accounting for approximately 60 % of all pediatric mediastinal lesions. These arise from the thymus and/or the mediastinal lymph nodes. Two-thirds are non-Hodgkin’s lymphomas and one-third are Hodgkin’s disease [10, 11]. T-cell lymphoblastic lymphomas are the most common histologic subtype of non-Hodgkin’s lymphomas, followed by large cell lymphomas [11, 12].
Children with non-Hodgkin’s lymphoma frequently present with symptoms related to local compression such as tachypnea, cough, stridor, and occasionally superior vena cava syndrome (Fig. 27.3). Up to 55 % of children with mediastinal Hodgkin’s lymphoma have radiographic evidence of tracheal compression (Fig. 27.4) [13]. Pleural effusion and cervical lymphadenopathy are frequently present and should be the first choice for obtaining cells or tissue for diagnosis [14]. These tumors have an excellent response to chemotherapy and radiotherapy despite the fact that disseminated disease is often present [1]. Peripherally-inserted central venous access should be obtained during diagnostic procedures performed under local anesthesia when contraindications to general anesthesia are present. The surgeon’s role is to obtain adequate tissue for diagnostic studies with minimal morbidity. Diagnosis and differentiation of histologic subtypes based on immunohistochemistry, cytogenetics and flow cytometry have significant impact on treatment regimen, thus sufficient diagnostic material need to be obtained prior to the initiation of chemotherapy. Recent advancement in molecular genetic testing utilizing fluorescent in situ hybridization and polymerase chain reaction may allow diagnosis with smaller amounts of tissue obtained from percutaneous fine needle aspiration or core biopsies [15, 16]. An open procedure with excision of the entire lymph node provides the best approach for adequate tissue diagnosis and assessment of nodal architecture [11]. However, the risk of anesthetic complication from the mass effect of the large mediastinal mass should be carefully assessed prior to any procedure as discussed in section “Anesthetic consideration for patients with mediastinal tumors”.
In patients without extra-thoracic disease, pretreatment with steroids or radiation prior to biopsy may reduce tumor size rapidly and allow for safer anesthesia. However, radiation may significantly alter pathology making the correct diagnosis difficult. In some cases the radiation field can be adjusted to spare an area for later biopsy. Pretreatment with steroids may also ablate tumor and cellular architecture as well as cytogenetic markers, leading to inaccurate diagnosis [17, 18] but may be necessary in the face of overwhelming anesthetic risk.
The staging, treatment and prognosis for lymphomas are discussed in Chap. 20.
Teratomas and Germ Cell Tumors
Germ cell tumors account for 6–18 % of pediatric mediastinal neoplasms [19]; they are the second most common tumor of the anterior mediastinum in children. They are believed to derive from primordial germ cells that missed their “target” during migration and remained in the mediastinum. Eighty-six percent are benign mature teratomas containing all three germinal layers, and the rest contain various malignant components including seminomas and non-seminomas.
Teratomas
Overall, 7–10 % of all teratomas are mediastinal, making this the third most common site after the sacrococcygeal and gonadal primaries [20]. Teratomas may present at any age from infancy to adolescence. The majority are benign, but after adolescence mediastinal teratomas have a high incidence of malignant behavior, which is usually indicated by elevated levels of tumor markers (alpha fetoprotein and beta-HCG) [20]. Immature elements are not of prognostic significance in children under 15 years, but they are associated with local aggressiveness and distant metastases above that age [21, 22]. Most mediastinal teratomas are located in the anterior mediastinum and frequently have large cystic components (Fig. 27.5), but a few have been described in the posterior mediastinum, some with epidural extension. Intrapericardial and intracardiac lesions are also described, the former presenting in utero or at birth with fetal hydrops or massive pericardial effusion [20]. Infants and toddlers with an anterior mediastinal teratoma commonly present with respiratory distress, but in older children, the teratoma may be an incidental finding on chest radiograph. It may also present as a chest wall mass with erosion through the soft tissues (Fig. 27.6), with hemoptysis or trichoptysis from bronchial erosion, with rupture into the pleural cavity, or with cardiac failure [20, 22]. CT scan is the imaging technique of choice in the evaluation of these lesions. It can define the extent of the lesion and possible tracheal compression. A heterogeneous anterior mediastinal mass containing calcification and varying tissue densities including fat is highly suggestive of the diagnosis [23]. Surgical resection via anterior thoracotomy, median sternotomy or thoracoscopy [24] is usually curative, although if present, malignant elements in the tumor will require further therapy.
Malignant Germ Cell Tumors
The mediastinum is the primary site in 4 % of malignant germ cell tumors [25]. These are complex tumors of varied histology with frequent coexistence of benign elements [26]. Malignant components include yolk sac tumors (also known as endodermal sinus tumors), seminomas, dysgerminomas, embryonal carcinomas, and choriocarcinomas [27]. They are more common in boys than girls (3:1). A strong association is found in patients with Klinefelter’s syndrome, who often present with precocious puberty from the choriocarcinoma elements [20]. AFP and β-HCG should be obtained preoperatively, as for suspected germ cell tumors in other locations. Elevated serum AFP will lead to suspicion of malignant yolk sac component, and high serum β-HCG is likely from the choriocarcinoma elements. Diagnostic biopsy should be obtained for large tumors considered difficult to resect either with image-guided core needle biopsy or via an anterior mediastinal approach [27]. Both can be safely performed under local anesthesia should the patient present with significant respiratory symptoms. The prognosis for patients with malignant germ cell tumors arising in the mediastinum was regarded previously as dismal with only occasional survivors in the pre-chemotherapy era [28, 29]. The POG/CCSG intergroup study demonstrated successful reduction in tumor bulk with neoadjuvant chemotherapy, which allowed complete resection of tumors with malignant components in 82 % of patients [27]. With the combination of multiagent chemotherapy (cisplatin, etoposide and bleomycin) and aggressive surgical resection, the POG/CCSG intergroup study reported 83 % 5-year overall survival and 79 % event-free survival in patients with extragonadal malignant germ cell tumors [29]. Similar results were reported by the United Kingdom Children’s Cancer Study Group and the French MGCT study, utilizing carboplatin instead of cisplatin to minimize renal toxicity and hearing loss [30, 31]. However, children older than 12 years of age with thoracic primaries had a six times higher risk of death compared with younger children with other primary sites. An alternative high dose cisplatin regimen offered better event-free survival than standard dose cisplatin, but at the cost of increased treatment related toxicities and secondary malignancies [32].
The management of primary mediastinal germ cell tumors should be conservative at diagnosis, with biopsy only for large tumors. Patients with elevated tumor markers or histologic confirmation of malignancy should receive neoadjuvant chemotherapy prior to attempt at resection. Benign tumors and masses persisting after chemotherapy (often due to coexisting benign teratomatous elements) should be resected aggressively, and an excellent outcome can be expected [33].
Thymic Tumors
Tumors or tumor-like lesions arising from the thymus include thymic hyperplasia, thymic cysts, thymomas, and thymolipomas. These lesions represent less than 5 % of resected mediastinal tumors in children.
Thymic hyperplasia may take the form of lymphoid follicular hyperplasia with or without thymic enlargement. These are often present in autoimmune diseases such as myasthenia gravis and Grave’s disease, and associated with a favorable response to thymectomy. True thymic hyperplasia can present as massive hypertrophy in children; surgical resection is only indicated in symptomatic patients when the diagnosis is unclear (Fig. 27.7); otherwise a short course of steroids will shrink the lesion. Thymic rebound hyperplasia is seen in children who have received systemic chemotherapy, usually within 2 years of initiation. It is a self-limited process and spontaneous resolution is expected [34, 35]. The diagnostic dilemma in patients who have been treated for mediastinal lymphoma is to distinguish thymic rebound from recurrent or metastatic tumor. Thymic rebound hyperplasia appears as diffuse enlargement with a fine mixture of fat and lymphoid tissue, a smooth contour, and normal appearing vessels on imaging studies. Recurrent neoplasia usually has a nodular contour and often contains necrotic or calcified foci [36]. Recovery from recent stress such as thermal burn or systemic illness can also result in thymic hyperplasia.
Thymic cysts are thin-walled, usually unilocular cysts containing thymic tissue in the cyst wall. They often extend from the mediastinum to the neck and are benign. Most are asymptomatic but hemorrhage into the cyst cavity or secondary infection may lead to tracheal compression and respiratory distress. Surgical excision is curative in symptomatic patients and is recommended in asymptomatic patients with large cysts to prevent complications.
Thymomas are rare in children as compared to adults, with only 2 % presenting in the first two decades of life. They are usually benign and arise in the upper anterior mediastinum or at the base of the neck. Although they may be massive in size, they generally compress adjacent structures rather than invade them. Respiratory distress and superior vena cava syndrome may occur [37]. They are occasionally associated with myasthenia gravis. Surgical resection is curative and recurrence is rare (2 %) [38]. Malignant thymomas are epithelial in nature and invasive as in adults. Aggressive surgical resection is critical as response to chemotherapy and radiotherapy is limited. Resection of lung, pleura, diaphragm, superior vena cava and pericardium may be required to achieve complete surgical extirpation.
Thymolipoma is a rare benign tumor of the thymus that often attains gigantic proportions in clinically asymptomatic patients (Fig. 27.8). Associated conditions such as myasthenia gravis [39], aplastic anemia [40], Graves’ disease [41], and Hodgkin’s disease [42], although possibly coincidental, have been reported in adult patients. One case of erythrocyte hypoplasia and hypogammaglobulinemia has been reported in a child [43]. Thymolipomas show fatty attenuation mixed with fibrous septae and normal thymic tissue on CT scan; on MRI, they demonstrate high signal intensity on both T1 and T2 weighted images along with strands of lower signal intensity at the fibrous septae [36]. Histologically a thymolipoma is composed of thymic and mature adipose tissue. The tumor usually extends inferiorly to either side of the mediastinum. Surgical resection is necessary for definitive diagnosis and can be accomplished thoracoscopically as these tumors tend to be pliable and rarely invade neighboring structures [43, 44].
Lymphangiomas
Lymphatic malformations are the most common vascular anomalies found in the anterior mediastinum. Isolated lymphatic malformations of the mediastinum are rare and can be found in all three compartments. Most mediastinal lymphangiomas are in fact extensions of cervical, axillary or chest wall lesions. These lesions are congenital in nature and are usually asymptomatic; spontaneous resolution is uncommon but has been observed. Symptoms often develop as a result of infection, hemorrhage, or cyst expansion, leading to the need for intervention. Complete surgical resection can be difficult and lead to significant morbidity as these lesions tend to infiltrate between vital structures. Percutaneous aspiration and sclerotherapy has been gaining popularity for both primary and recurrent lesions. Several sclerosing agents have been reported to yield good results, including OK-432, alcoholic solution of zein (Ethibloc), bleomycin and doxycycline [45, 46]. OK-432 is the most commonly reported agent in the literature, favored by Japanese and European surgeons with good to excellent outcomes, but is not clinically available in North America. Alcoholic solution of zein is widely used in Europe and Canada with favorable results as well. However, there is no standardized regimen in the administration of sclerosing therapy as the literature is comprised of mostly case reports and expert opinions [34, 47], and there is limited experience with large mediastinal lesions. Surgical resection remains an excellent option for macrocystic lesions without infiltration of vital structures. A combined thoracoscopic drainage and sclerotherapy is also a viable option for lesions not accessible percutaneously (Fig. 27.9).
Others
Angiofollicular or giant lymph node hyperplasia (also called Castleman’s disease) is usually a benign condition, which most commonly affects mediastinal nodes. The grossly enlarged nodes are very vascular on imaging studies. Excisional biopsy is required to differentiate this from lymphoma. The disease sometimes takes a systemic form, in which case the course is complicated with anemia and growth failure. These manifestations sometimes improve with excision of the enlarged node(s) if easily accessible, but aggressive surgical resection should be avoided [48].
Langerhans cell histiocytosis in the mediastinum is usually part of a multifocal systemic disease, but rarely may present as an isolated thymic mass. Superior vena cava syndrome has been described. The prognosis for unifocal mediastinal disease is excellent [37].
Among the less common mediastinal tumors, there are reports of lipomas and lipoblastomas, and rare instances of liposarcoma. Other sarcomas such as rhabdomyosarcomas, Ewing tumors, mesenchymomas and other unusual neoplasms may also occur [37]. Rare cases of fibromatosis have also been described in the mediastinum.
Middle Mediastinal Tumors
The middle mediastinum is also known as the visceral compartment, containing the trachea and mainstem bronchi, the heart and the great vessels. Lymphoid tissues are also abundant in this region, thus lymphomas are the most common tumors, often involving both the anterior and middle mediastinum. Benign vascular tumors and lymphatic malformations are also found here. Gorham’s disease is worth mentioning; even though it is not a tumor per se, it behaves as one. Gorham’s disease or “vanishing bone disease” is a rare disorder of unknown etiology, characterized by proliferation of vascular channels that results in the destruction and resorption of the osseous matrix [49]. Some consider it as an extreme form of lymphangiomatosis [50]. The shoulder and the pelvis are the most commonly affected sites; however, various locations in all of the other areas of the skeleton have also been reported. The disease may present with pain from lytic bony lesions and pathological fractures, or with chylous pericardial or pleural effusions, which may be life-threatening. These effusions may be due to mediastinal extension of the disease process from the involved vertebrae, scapulae, ribs or sternum, or may represent a direct lymphangiomatous involvement of the mediastinum. In general, mediastinal and spinal involvement are associated with a poor prognosis. The treatment is mostly supportive, with isolated trials of radiation therapy, anti-osteoclastic and anti-angiogenic medications including pamidronate, zoledronic acid and alpha-2b interferon [51]. Pleurodesis and pleuroperitoneal shunts may be useful for symptomatic relief. The disease occasionally becomes quiescent after adolescence.
Bronchogenic cysts are benign congenital lesions that can present with symptoms of tracheal compression or recurrent pulmonary infections. The treatment is complete surgical excision [52] (Fig. 27.10).
Posterior Mediastinal Tumors
Neurogenic Tumors
Tumors of neural crest origin are the most common posterior mediastinal lesions. They arise from the sympathetic chain and range from benign ganglioneuroma to malignant neuroblastoma. Twenty percent of neurogenic tumors are located in the mediastinum. Neuroblastoma is the most common tumor and occurs mostly in infants and young children (Table 27.2). Ganglioneuromas present in older children and teenagers as asymptomatic lesions, which are identified incidentally on chest radiographs obtained for unrelated reasons. Radiographically they appear as paraspinal spindle-shaped lesions and are frequently calcified. Neurogenic tumors may occur anywhere along the paraspinal sulcus from the thoracic inlet to the diaphragm. They can present as incidental paraspinal mass on routine chest radiograph, or can be identified on investigations performed for Horner’s syndrome, ataxia or opsoclonus myoclonus. When the tumor extends into the spinal canal, it may present with signs and symptoms of cord compression. Investigations for paraspinal posterior mediastinal masses should include a CT scan or MRI prior to surgical resection to better define the relationship to surrounding structures and assess possible spinal extension (Fig. 27.11). Spot urinary catecholamines should also be obtained. A preoperative MIBG scan is recommended to determine local tumor extent and presence of distant metastases, and will be a useful modality for postoperative monitoring when the tumor is MIBG avid.
Most mediastinal neurogenic tumors are well encapsulated and readily resectable, unlike their abdominal counterparts. Surgical resection is the treatment of choice and is curative for benign lesions such as ganglioneuromas. Several recent series have reported successful thoracoscopic resections, but removal within an endobag is essential to prevent tumor spillage [24]. The tumor can be closely adherent to the posterior part of the ribs and necessitates removal of part of the periosteum. Often it is impossible to avoid leaving small amounts of residual disease along the sympathetic nerve roots as they emerge from the foramina. These areas are simply marked with small titanium clips for future imaging. For upper thoracic neuroblastomas, a temporary or permanent Horner’s syndrome is a normal postoperative “complication”, especially when present preoperatively. Adequate sampling of ipsilateral lymph nodes is essential to determine surgical staging in neuroblastomas, as patients with stage L1 disease according to the International Neuroblastoma Risk Group Staging System (INRGSS) may be observed after a macroscopically complete surgical excision. Ipsilateral nodes are excised if any are visible, but extensive sampling, including contralateral nodes, is not required for thoracic neuroblastomas, unlike for their abdominal counterpart. Patients with thoracic neuroblastomas tend to have a better prognosis (see Chap. 13 for a complete discussion on neuroblastoma).
The optimal treatment for patients presenting with symptomatic spinal cord compression at diagnosis has evolved. Treatment of the so called ‘dumbbell’ lesions with significant extension into the spinal canal must first involve control of the spinal lesion by laminectomy/laminotomy, radiation, or chemotherapy [53]. Initial resection of the thoracic component entails the risk of potential swelling of the spinal tumor with worsening of neurologic compression and paralysis [6, 54]. Recent studies from France, Italy and the Pediatric Oncology Group all demonstrated equal efficacy between laminectomy, radiation, and chemotherapy to relieve or improve neurologic deficits. However, patients treated with chemotherapy usually did not require additional treatment and have less orthopedic sequelae, whereas patients treated either with radiotherapy or laminectomy commonly did [55–57]. Although laminotomy may be a worthwhile alternative with fewer sequelae than laminectomy, the current trend is to use chemotherapy for debulking, now that the fear of inducing tumor necrosis, resulting in edema and increased cord compression, has been dispelled. Surgical decompression is reserved for patients who show progressive neurologic deterioration after initiation of chemotherapy [58]. The frequency of complete neurologic recovery in children with intraspinal neuroblastoma inversely correlates with the duration and severity of the presenting neurologic deficits [56], and up to 44 % have permanent disabilities [55].
Prognosis in neuroblastoma is age-dependent, with a better prognosis for infants compared to older children. Intrathoracic neuroblastomas have a more favorable prognosis than abdominal primaries of comparable stage [58, 59]. This is most likely related to the favorable biology of most thoracic neurogenic lesions [60, 61]. In the presence of a maturing ganglioneuroblastoma, it is important to remember that the tumor is as malignant as its most malignant component. A small proportion of older children with thoracic neuroblastoma appear to have a protracted course, with late recurrences and death.
Others
Plexiform neurofibroma may occur in the mediastinum as an isolated lesion or in patients with neurofibromatosis (NF 1 or von Recklinghausen’s disease). Resection is required for isolated lesions in order to obtain a histologic diagnosis [62]. In patients with neurofibromatosis, resection is required if the lesions are symptomatic. Rapid growth usually occurs if there is malignant transformation to malignant peripheral nerve sheath tumor (Fig. 27.12). MRI and PET scan are both useful to detect malignant transformation in NF 1 patients [63, 64].
Pheochromocytoma (also called paraganglioma) can also occur along the sympathetic chain in the neck and mediastinum and produce symptoms of compression as well as flushing and hypertension. This tumor has been described in the anterior mediastinum as well. Regional or distant metastases are seen in 15–20 % of patients [37]. Other rare neurogenic tumors include neurilemmoma and malignant schwannoma.
Anesthetic Consideration for Patients with Mediastinal Tumors
Risk Assessment
The majority of patients with mediastinal tumors tolerate general anesthesia well with a reported anesthetic complication rate of <10 % [65]. However, respiratory or hemodynamic collapse during induction of general anesthesia is a recognized risk in children with an anterior mediastinal mass. The increased risk is contributed by several factors, and can be understood as restrictive or obstructive ventilatory compromises, decreased venous return and increased pulmonary pressure with right-sided heart failure. Restrictive compromise is contributed by decreased functional residual capacity and decreased lung compliance. Obstructive changes are evident by the decreased airway diameter and worsened under anesthesia by the loss of normal bronchial smooth muscle tone and distal airway collapse.
An algorithm depicting the assessment of critical airway and the appropriate diagnostic procedure is illustrated in Fig. 27.13 [8–10]. Anesthetic risks should be considered with the combination of clinical, radiological, and functional data. Clinical signs and symptoms alone do not correlate well with anesthetic complications. Several recent studies have also shown that the degree of airway and vascular compression correlates poorly with actual clinical symptoms. [8, 66, 67] The only symptom that is strongly associated with respiratory collapse is orthopnea [5, 68, 69]. Thus patients presenting with orthopnea should avoid general anesthesia for either diagnostic or therapeutic procedures as a general rule.
Historically, children with a mediastinal mass less than one-third of the diameter of the thorax have a low risk of anesthetic complications, and those with a mass greater than 45 % of chest diameter are thought to have the greatest risk [1, 70]. As technology advanced, CT scans became routinely used to define the cross-sectional area of the trachea to assess the relationship to anesthetic risk [69, 71, 72]. Both Azizkhan et al and Shamberger et al suggested that children with tracheal cross-sectional areas (TCA) less than 50 % of predicted should not receive a general anesthetic. A recent retrospective series in the anesthesia literature reported imaging findings of mainstem bronchus compression and great vessel compression, along with orthopnea and upper body edema, as significantly associated with anesthetic complications in children with anterior mediastinal masses [65].
Extensive pulmonary function abnormalities were identified in a group of patients with anterior mediastinal masses prospectively studied [72]. The peak expiratory flow rate (PEFR) in pulmonary function studies is the best parameter in the prediction of anesthetic problems. It provides a quantitative reflection of central airway size. It can be easily performed with a hand-held device and compared with the predicted values [10, 72]. A PEFR of less than 50 % of predicted is associated with increased anesthetic risks [69]. The measurement of pulmonary function in children with anterior mediastinal masses may add valuable information to the anatomic evaluation obtained by CT scan. In particular, it can quantitate the magnitude of pulmonary restriction in relation to the size of the mass and may identify impairment of flow related to compression of airways distal to the carina, which cannot be measured by CT scan. Thus, the clinical, functional, and radiological findings can be incorporated into a simple algorithm to assess anesthetic risk for each individual patient (Fig. 27.13).
Alternatives to General Anesthesia for Diagnosis
The least invasive and lowest risk technique should be utilized first to diagnose a mediastinal mass [9]. A multidisciplinary approach in the decision making is essential for optimal patient care. An extra-thoracic approach under local anesthesia can be performed in most patients with anterior mediastinal masses to obtain diagnostic material. This includes cervical or supraclavicular excision of an enlarged lymph node, thoracentesis in the presence of pleural effusion to obtain cells for cytology and flow cytometry [14], and bone marrow aspirate and biopsy since leukemias may present as an anterior mediastinal mass (Fig. 27.14). Fine needle aspiration and core-needle biopsies of mediastinal masses under CT or ultrasound guidance is generally adequate to obtain a pathologic diagnosis, but frequently does not provide sufficient material for histologic subtyping for lymphomas [73–76]. The Chamberlain procedure (anterior thoracotomy through the bed of the second rib) can be performed under local anesthesia even in children, and should be part of the armamentarium of the pediatric surgeon [77]. Thoracoscopic biopsy requires general anesthesia, and its diagnostic accuracy for lymphoma is still under investigation, despite excellent diagnostic yields for other thoracic lesions using minimally invasive techniques [78, 79]. Careful communication with the pathologist regarding the adequacy of biopsy material is essential when utilizing a minimally invasive technique. [80, 81]
Management of General Anesthesia
Despite the increased anesthetic risk, surgical biopsy or resection under general anesthesia remains the optimal option for some children with mediastinal tumors. Thus, careful preoperative discussion must occur between the surgeon and the anesthesiologist to provide an individualized management plan based on the child’s preoperative symptoms and imaging findings (Figs. 27.15 and 27.16). Airway management maybe achieved with awake fiberoptic bronchoscopy using local anesthesia and judicious intravenous sedation. Rigid bronchoscopy performed by the surgeon may be necessary in the event of airway loss, passing the scope beyond a mid-tracheal narrowing or placing it into a patent mainstem bronchus to allow for adequate ventilation until spontaneous ventilation returns. Identifying a “rescue” position preoperatively may be helpful to minimize cardiorespiratory collapse [82].
Extracorporeal Membrane Oxygenation (ECMO) providing cardiopulmonary bypass is the final option in the management of critical mediastinal masses [83–85]. The best time to consider ECMO is prior to anesthesia induction. Cannulation options should be discussed and decided, and a circuit should be primed and ready (Fig. 27.17). A femoral approach with distal limb perfusion is the preferred method as the cervical approach would likely be compromised by the presence of the tumor [85].
Video Assisted Thoracoscopic Surgery (VATS)
Surgical biopsy and resection is essential in the management of pediatric mediastinal tumors. Anterior mediastinal masses are traditionally approached with median sternotomy or anterior thoracotomy, and posterolateral thoracotomy for posterior mediastinal lesions. Increased expertise in minimally invasive surgery has allowed VATS to be applied in the surgical management of mediastinal pathologies.
VATS offers several advantages over traditional open thoracotomy and sternotomy both for the surgeon and the patient. Thoracoscopy provides greater exposure of the entire thoracic and mediastinal compartments and wider area of access. The magnification also gives better anatomic detail. The video monitor affords the anesthesiologists and trainees a better understanding of the procedure. Patient-related advantages include less postoperative pain, less splinting, and less atelectasis [86]. The risk of skeletal deformities such as scoliosis and chest wall asymmetry is minimized with the thoracoscopic approach [87]. Shorter hospital stay and earlier return to normal activity for both patient and parents have been well documented in the literature. Conversely, potential problems with the use of thoracoscopy for biopsy include the inability to palpate lesions, the risk of intrapleural tumor spillage and the development of recurrent disease at the port sites.
Both benign and malignant conditions can be treated with VATS (Figs. 27.2, 27.9, 27.10 and 27.15). Benign mediastinal cysts and tumors can be safely resected with VATS. Biopsy, staging and even curative resection can be achieved with VATS in selected patients with malignant lesions. Even young infants tolerate VATS with few complications. In one report, 38 of 39 procedures were completed successfully using VATS [24]. Diagnosis was obtained in all cases, and complete resection was performed in 33 children who were appropriate candidates.
Relative contraindications for VATS include previous thoracotomy and significant bleeding disorder. Patients with airway compromise from large anterior mediastinal mass may require alternative diagnostic methods.
Single Lung Ventilation
A detailed discussion regarding airway management should be carried out between the surgeon and the anesthesiologist preoperatively. Single lung ventilation is essential to provide optimal exposure of the mediastinum. It can be achieved with double lumen endotracheal tubes in older children, and mainstem intubation or selective contralateral lung ventilation using ipsilateral bronchial blockers for smaller children [88]. The use of low pressure, low flow of CO2 (3–5 mmHg) also helps to collapse the ipsilateral lung. Placement of a chest tube at the end of the procedure is procedure-dependent and at the discretion of the surgeon.
Positioning and Port Placement
Patients with anterior mediastinal masses should be positioned in a modified supine position with the affected side elevated slightly (15–45°). Patients with posterior masses are positioned in a modified prone position with a similar degree of elevation. Such positioning takes advantage of gravity to allow the lung to fall away from the lesion when the lung is collapsed. Three or four ports are placed between the anterior and posterior axillary lines. Entry into the thoracic cavity at the fourth or fifth interspace is optimal, as the collapsed lung from single lung ventilation may elevate the ipsilateral diaphragm.
VATS provides a safe and effective approach in the surgical management of mediastinal tumors [89]. This approach is the author’s preferred method in appropriate patients with mediastinal masses, as long as basic oncologic surgical principles are upheld without compromising patient safety.
Conclusion
The majority of pediatric mediastinal masses are malignant. Anatomical assessment and knowledge of representative tissue in each compartment will provide an organized approach to the differential diagnosis. Age of the patient, imaging modalities and tumor markers (when present) are additional useful factors. Early diagnosis, resection of non-lymphomatous tumors, and adjunctive treatment can result in improved survival. Careful assessment of anesthetic risk factors in patients with large anterior mediastinal masses can avoid significant anesthetic complications. VATS offers the advantage of smaller incisions, better visualization, and faster recovery with low morbidity. VATS can be used safely in the evaluation and treatment of some mediastinal malignancies.
References
King RM, Telander RL, Smithson WA, Banks PM, Han MT. Primary mediastinal tumors in children. J Pediatr Surg. 1982;17(5):512–20.
Grosfeld JL, Skinner MA, Rescorla FJ, West KW, Scherer 3rd LR. Mediastinal tumors in children: experience with 196 cases. Ann Surg Oncol. 1994;1(2):121–7.
Zhurilo IP, Kononuchenko VP, Litovka VK, Moskalenko VZ, Sopov GA, Veselyi SV, et al. [Mediastinal tumors and tumor-like formations in children]. Klin Khir. 2001(9):44–7. Mediastinal’nye opukholi i opukholepodobnye obrazovaniia u detei.
Gun F, Erginel B, Unuvar A, Kebudi R, Salman T, Celik A. Mediastinal masses in children: experience with 120 cases. Pediatr Hematol Oncol. 2012;29(2):141–7. Epub 2012/03/02.
Freud E, Ben-Ari J, Schonfeld T, Blumenfeld A, Steinberg R, Dlugy E, et al. Mediastinal tumors in children: a single institution experience. Clin Pediatr. 2002;41(4):219–23. Epub 2002/06/04.
Saenz NC, Schnitzer JJ, Eraklis AE, Hendren WH, Grier HE, Macklis RM, et al. Posterior mediastinal masses. J Pediatr Surg. 1993;28(2):172–6.
Newman B. Thoracic neoplasms in children. Radiol Clin North Am. 2011;49(4):633–64. v. Epub 2011/08/03.
Garey CL, Laituri CA, Valusek PA, St Peter SD, Snyder CL. Management of anterior mediastinal masses in children. Eur J Pediatr Surg. 2011;21(5):310–3. Epub 2011/07/14.
Perger L, Lee EY, Shamberger RC. Management of children and adolescents with a critical airway due to compression by an anterior mediastinal mass. J Pediatr Surg. 2008;43(11):1990–7. Epub 2008/10/31.
Ricketts RR. Clinical management of anterior mediastinal tumors in children. Semin Pediatr Surg. 2001;10(3):161–8.
Glick RD, La Quaglia MP. Lymphomas of the anterior mediastinum. Semin Pediatr Surg. 1999;8(2):69–77.
Murphy SB, Fairclough DL, Hutchison RE, Berard CW. Non-Hodgkin’s lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution. J Clin Oncol. 1989;7(2):186–93.
Mandell GA, Lantieri R, Goodman LR. Tracheobronchial compression in Hodgkin lymphoma in children. AJR Am J Roentgenol. 1982;139(6):1167–70.
Chaignaud BE, Bonsack TA, Kozakewich HP, Shamberger RC. Pleural effusions in lymphoblastic lymphoma: a diagnostic alternative. J Pediatr Surg. 1998;33(9):1355–7.
Safley AM, Buckley PJ, Creager AJ, Dash RC, Dodd LG, Goodman BK, et al. The value of fluorescence in situ hybridization and polymerase chain reaction in the diagnosis of B-cell non-Hodgkin lymphoma by fine-needle aspiration. Arch Pathol Lab Med. 2004;128(12):1395–403. Epub 2004/12/08.
da Cunha Santos G, Ko HM, Geddie WR, Boerner SL, Lai SW, Have C, et al. Targeted use of fluorescence in situ hybridization (FISH) in cytospin preparations: results of 298 fine needle aspirates of B-cell non-Hodgkin lymphoma. Cancer Cytopathol. 2010;118(5):250–8. Epub 2010/09/24.
Kan E, Levi I, Benharroch D. Alterations in the primary diagnosis of lymphomas pretreated with corticosteroid agents. Leuk Lymphoma. 2011;52(3):425–8. Epub 2011/02/18.
Borenstein SH, Gerstle T, Malkin D, Thorner P, Filler RM. The effects of prebiopsy corticosteroid treatment on the diagnosis of mediastinal lymphoma. J Pediatr Surg. 2000;35(6):973–6. Epub 2000/06/29.
Billmire DF. Germ cell, mesenchymal, and thymic tumors of the mediastinum. Semin Pediatr Surg. 1999;8(2):85–91.
Laberge J-M, Puligandla PS, Shaw K. Teratomas, dermoids and other soft tissue tumors, chap 68. In: Holcomb G, Murphy J, editors. Ashcraft’s pediatric surgery. 6th ed. Philadelphia: Elsevier Saunders; 2013.
Carter D, Bibro MC, Touloukian RJ. Benign clinical behavior of immature mediastinal teratoma in infancy and childhood: report of two cases and review of the literature. Cancer. 1982;49(2):398–402.
Ozergin U, Gormus N, Aribas OK, Durgut K, Yuksek T. Benign mature cystic teratoma of the anterior mediastinum leading to heart failure: report of a case. Surg Today. 2003;33(7):518–20.
Moeller KH, Rosado-de-Christenson ML, Templeton PA. Mediastinal mature teratoma: imaging features. AJR Am J Roentgenol. 1997;169(4):985–90.
Partrick DA, Rothenberg SS. Thoracoscopic resection of mediastinal masses in infants and children: an evaluation of technique and results. J Pediatr Surg. 2001;36(8):1165–7.
Gobel U, Schneider DT, Calaminus G, Haas RJ, Schmidt P, Harms D. Germ-cell tumors in childhood and adolescence. GPOH MAKEI and the MAHO study groups. Ann Oncol. 2000;11(3):263–71. Epub 2000/05/16.
Billmire DF. Germ cell tumors. Surg Clin North Am. 2006;86(2):489–503, xi.
Billmire D, Vinocur C, Rescorla F, Colombani P, Cushing B, Hawkins E, et al. Malignant mediastinal germ cell tumors: an intergroup study. J Pediatr Surg. 2001;36(1):18–24.
Lack EE, Weinstein HJ, Welch KJ. Mediastinal germ cell tumors in childhood. A clinical and pathological study of 21 cases. J Thorac Cardiovasc Surg. 1985;89(6):826–35.
Marina N, London WB, Frazier AL, Lauer S, Rescorla F, Cushing B, et al. Prognostic factors in children with extragonadal malignant germ cell tumors: a pediatric intergroup study. J Clin Oncol. 2006;24(16):2544–8.
Mann JR, Raafat F, Robinson K, Imeson J, Gornall P, Sokal M, et al. The United Kingdom children’s Cancer Study Group’s second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity. J Clin Oncol. 2000;18(22):3809–18. Epub 2000/11/15.
Baranzelli MC, Flamant F, De Lumley L, Le Gall E, Lejars O. Treatment of non-metastatic, non-seminomatous malignant germ-cell tumours in childhood: experience of the “Societe Francaise d’Oncologie Pediatrique” MGCT 1985–1989 study. Med Pediatr Oncol. 1993;21(6):395–401. Epub 1993/01/01.
Cushing B, Giller R, Cullen JW, Marina NM, Lauer SJ, Olson TA, et al. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--pediatric oncology group 9049 and Children’s Cancer Group 8882. J Clin Oncol. 2004;22(13):2691–700. Epub 2004/07/01.
Billmire DF. Malignant germ cell tumors in childhood. Semin Pediatr Surg. 2006;15(1):30–6.
Impellizzeri P, Romeo C, Borruto FA, Granata F, Scalfari G, De Ponte FS, et al. Sclerotherapy for cervical cystic lymphatic malformations in children. Our experience with computed tomography-guided 98% sterile ethanol insertion and a review of the literature. J Pediatr Surg. 2010;45(12):2473–8. Epub 2010/12/07.
Wright CD. Mediastinal tumors and cysts in the pediatric population. Thorac Surg Clin. 2009;19(1):47–61. vi. Epub 2009/03/18.
Nasseri F, Eftekhari F. Clinical and radiologic review of the normal and abnormal thymus: pearls and pitfalls. Radiographics. 2010;30(2):413–28. Epub 2010/03/17.
Dehner L. Mediastinum, lungs, and cardiovascular system. In: Dehner L, editor. Pediatric surgical pathology. 2nd ed. Baltimore: Williams & Wilkins; 1997. p. 229–333.
Welch KJ, Tapper D, Vawter GP. Surgical treatment of thymic cysts and neoplasms in children. J Pediatr Surg. 1979;14(6):691–8.
Pan CH, Chiang CY, Chen SS. Thymolipoma in patients with myasthenia gravis: report of two cases and review. Acta Neurol Scand. 1988;78(1):16–21.
Barnes RD, O’Gorman P. Two cases of aplastic anaemia associated with tumours of the thymus. J Clin Pathol. 1962;15:264–8.
Carvalho MR, Dias T, Baptista F, do Carmo I. Graves’ disease and massive thymic hyperplasia. Thyroid Off J Am Thyroid Assoc. 2010;20(2):227–9. Epub 2010/02/16.
Pillai R, Yeoh N, Addis B, Peckham M, Goldstraw P. Thymolipoma in association with Hodgkin’s disease. J Thorac Cardiovasc Surg. 1985;90(2):306–8.
Kitano Y, Yokomori K, Ohkura M, Kataoka T, Narita M, Takemura T. Giant thymolipoma in a child. J Pediatr Surg. 1993;28(12):1622–5.
Ferrari G, Paci M, Sgarbi G. Thymolipoma of the anterior mediastinum: videothoracoscopic removal using a bilateral approach. Thorac Cardiovasc Surg. 2006;54(6):435–7.
Shergill A, John P, Amaral JG. Doxycycline sclerotherapy in children with lymphatic malformations: outcomes, complications and clinical efficacy. Pediatr Radiol. 2012;42(9):1080–8. Epub 2012/06/01.
Jamal N, Ahmed S, Miller T, Bent J, Brook A, Parikh S, et al. Doxycycline sclerotherapy for pediatric head and neck macrocystic lymphatic malformations: a case series and review of the literature. Int J Pediatr Otorhinolaryngol. 2012;76(8):1127–31. Epub 2012/05/11.
Churchill P, Otal D, Pemberton J, Ali A, Flageole H, Walton JM. Sclerotherapy for lymphatic malformations in children: a scoping review. J Pediatr Surg. 2011;46(5):912–22. Epub 2011/05/28.
Farruggia P, Trizzino A, Scibetta N, Cecchetto G, Guerrieri P, D’Amore ES, et al. Castleman’s disease in childhood: report of three cases and review of the literature. Ital J Pediatr. 2011;37:50. Epub 2011/10/22.
Patel DV. Gorham’s disease or massive osteolysis. Clin Med Res. 2005;3(2):65–74.
Aviv RI, McHugh K, Hunt J. Angiomatosis of bone and soft tissue: a spectrum of disease from diffuse lymphangiomatosis to vanishing bone disease in young patients. Clin Radiol. 2001;56(3):184–90.
Mignogna MD, Fedele S, Lo Russo L, Ciccarelli R. Treatment of Gorham’s disease with zoledronic acid. Oral Oncol. 2005;41(7):747–50.
Laberge JM, Puligandla P, Flageole H. Asymptomatic congenital lung malformations. Semin Pediatr Surg. 2005;14(1):16–33.
Shimada Y, Sato K, Abe E, Suzuki T, Ishihara Y. Congenital dumbbell neuroblastoma. Spine. 1995;20(11):1295–300.
Boglino C, Martins AG, Ciprandi G, Sousinha M, Inserra A. Spinal cord vascular injuries following surgery of advanced thoracic neuroblastoma: an unusual catastrophic complication. Med Pediatr Oncol. 1999;32(5):349–52.
De Bernardi B, Pianca C, Pistamiglio P, Veneselli E, Viscardi E, Pession A, et al. Neuroblastoma with symptomatic spinal cord compression at diagnosis: treatment and results with 76 cases. J Clin Oncol. 2001;19(1):183–90.
Katzenstein HM, Kent PM, London WB, Cohn SL. Treatment and outcome of 83 children with intraspinal neuroblastoma: the pediatric oncology group experience. J Clin Oncol. 2001;19(4):1047–55.
Plantaz D, Rubie H, Michon J, Mechinaud F, Coze C, Chastagner P, et al. The treatment of neuroblastoma with intraspinal extension with chemotherapy followed by surgical removal of residual disease. A prospective study of 42 patients--results of the NBL 90 study of the french society of pediatric oncology. Cancer. 1996;78(2):311–9.
Laberge J. Neuroblastoma. In: O’Neill JJ, Grosfeld J, Fonkalsrud E, Coran A, Caldamone A, editors. Principles of pediatric surgery. 2nd ed. W.B. Saunders; 2003. p. 211–9.
McLatchie GR, Young DG. Presenting features of thoracic neuroblastoma. Arch Dis Child. 1980;55(12):958–62.
Adams GA, Shochat SJ, Smith EI, Shuster JJ, Joshi VV, Altshuler G, et al. Thoracic neuroblastoma: a pediatric oncology group study. J Pediatr Surg. 1993;28(3):372–7; discussion 7–8.
Morris JA, Shcochat SJ, Smith EI, Look AT, Brodeur GM, Cantor AB, et al. Biological variables in thoracic neuroblastoma: a pediatric oncology group study. J Pediatr Surg. 1995;30(2):296–302; discussion −3.
Raffensperger J, Cohen R. Plexiform neurofibromas in childhood. J Pediatr Surg. 1972;7(2):144–51.
Wasa J, Nishida Y, Tsukushi S, Shido Y, Sugiura H, Nakashima H, et al. MRI features in the differentiation of malignant peripheral nerve sheath tumors and neurofibromas. AJR Am J Roentgenol. 2010;194(6):1568–74. Epub 2010/05/22.
Bredella MA, Torriani M, Hornicek F, Ouellette HA, Plamer WE, Williams Z, et al. Value of PET in the assessment of patients with neurofibromatosis type 1. AJR Am J Roentgenol. 2007;189(4):928–35. Epub 2007/09/22.
Anghelescu DL, Burgoyne LL, Liu T, Li CS, Pui CH, Hudson MM, et al. Clinical and diagnostic imaging findings predict anesthetic complications in children presenting with malignant mediastinal masses. Paediatr Anaesth. 2007;17(11):1090–8. Epub 2007/09/28.
Hack HA, Wright NB, Wynn RF. The anaesthetic management of children with anterior mediastinal masses. Anaesthesia. 2008;63(8):837–46. Epub 2008/06/13.
Stricker PA, Gurnaney HG, Litman RS. Anesthetic management of children with an anterior mediastinal mass. J Clin Anesth. 2010;22(3):159–63. Epub 2010/04/20.
Lam JC, Chui CH, Jacobsen AS, Tan AM, Joseph VT. When is a mediastinal mass critical in a child? An analysis of 29 patients. Pediatr Surg Int. 2004;20(3):180–4. Epub 2004/04/06.
Shamberger RC. Preanesthetic evaluation of children with anterior mediastinal masses. Semin Pediatr Surg. 1999;8(2):61–8.
Turoff RD, Gomez GA, Berjian R, Park JJ, Priore RL, Lawrence DD, et al. Postoperative respiratory complications in patients with Hodgkin’s disease: relationship to the size of the mediastinal tumor. Eur J Cancer Clin Oncol. 1985;21(9):1043–6. Epub 1985/09/01.
Azizkhan RG, Dudgeon DL, Buck JR, Colombani PM, Yaster M, Nichols D, et al. Life-threatening airway obstruction as a complication to the management of mediastinal masses in children. J Pediatr Surg. 1985;20(6):816–22.
Shamberger RC, Holzman RS, Griscom NT, Tarbell NJ, Weinstein HJ, Wohl ME. Prospective evaluation by computed tomography and pulmonary function tests of children with mediastinal masses. Surgery. 1995;118(3):468–71.
Andersson T, Lindgren PG, Elvin A. Ultrasound guided tumour biopsy in the anterior mediastinum. An alternative to thoracotomy and mediastinoscopy. Acta Radiol. 1992;33(5):423–6.
Otani Y, Yoshida I, Ishikawa S, Ohtaki A, Kawashima O, Takahashi T, et al. Use of ultrasound-guided percutaneous needle biopsy in the diagnosis of mediastinal tumors. Surg Today. 1996;26(12):990–2.
Shabb NS, Fahl M, Shabb B, Haswani P, Zaatari G. Fine-needle aspiration of the mediastinum: a clinical, radiologic, cytologic, and histologic study of 42 cases. Diagn Cytopathol. 1998;19(6):428–36.
van de Schoot L, Aronson DC, Behrendt H, Bras J. The role of fine-needle aspiration cytology in children with persistent or suspicious lymphadenopathy. J Pediatr Surg. 2001;36(1):7–11.
Olak J. Parasternal mediastinotomy (chamberlain procedure). Chest Surg Clin N Am. 1996;6(1):31–40.
Lima M, Bertozzi M, Domini M, Pession A, Ruggeri G, Libri M, et al. Thoracoscopic management of suspected thoraco-pulmonary malignant diseases in pediatric age. Pediatr Med Chir. 2004;26(2):132–5. Management toracoscopico delle patologie toraco-polmonari di sospetta natura tumorale in eta pediatrica.
Rothenberg SS. Thoracoscopy in infants and children. Semin Pediatr Surg. 1998;7(4):194–201.
Rodgers BM, Ryckman FC, Moazam F, Talbert JL. Thoracoscopy for intrathoracic tumors. Ann Thorac Surg. 1981;31(5):414–20.
Ryckman FC, Rodgers BM. Thoracoscopy for intrathoracic neoplasia in children. J Pediatr Surg. 1982;17(5):521–4.
Blank RS, de Souza DG. Anesthetic management of patients with an anterior mediastinal mass: continuing professional development. Can J Anaesth. 2011;58(9):853–9, 60–7. Epub 2011/07/23.
Takeda S, Miyoshi S, Omori K, Okumura M, Matsuda H. Surgical rescue for life-threatening hypoxemia caused by a mediastinal tumor. Ann Thorac Surg. 1999;68(6):2324–6. Epub 2000/01/05.
Huang YL, Yang MC, Huang CH, Wang CC, Wu ET, Huang SC, et al. Rescue of cardiopulmonary collapse in anterior mediastinal tumor: case presentation and review of literature. Pediatr Emerg Care. 2010;26(4):296–8. Epub 2010/04/14.
Wickiser JE, Thompson M, Leavey PJ, Quinn CT, Garcia NM, Aquino VM. Extracorporeal membrane oxygenation (ECMO) initiation without intubation in two children with mediastinal malignancy. Pediatr Blood Cancer. 2007;49(5):751–4. Epub 2006/01/20.
Ure BM, Schmidt AI, Jesch NK. Thoracoscopic surgery in infants and children. Eur J Pediatr Surg. 2005;15(5):314–8. Epub 2005/10/29.
Lawal TA, Gosemann JH, Kuebler JF, Gluer S, Ure BM. Thoracoscopy versus thoracotomy improves midterm musculoskeletal status and cosmesis in infants and children. Ann Thorac Surg. 2009;87(1):224–8. Epub 2008/12/23.
Engum SA. Minimal access thoracic surgery in the pediatric population. Semin Pediatr Surg. 2007;16(1):14–26. Epub 2007/01/11.
Gow KW, Chen MK, New Technology C, Barnhart D, Breuer C, Brown M, et al. American pediatric surgical association new technology committee review on video-assisted thoracoscopic surgery for childhood cancer. J Pediatr Surg. 2010;45(11):2227–33. Epub 2010/11/03.
Laberge J-M, Nguyen LT, Shaw KS. Teratomas, dermoids and other soft tissue tumors, chap 68. In: Ashcraft KW, Holcomb GW, Murphy JP, editors. Pediatric surgery. 4th ed. Philadelphia: Elsevier Saunders; 2005. p. 972–96.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Su, W., Laberge, JM. (2016). Mediastinal Tumors. In: Carachi, R., Grosfeld, J. (eds) The Surgery of Childhood Tumors. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-48590-3_27
Download citation
DOI: https://doi.org/10.1007/978-3-662-48590-3_27
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-48588-0
Online ISBN: 978-3-662-48590-3
eBook Packages: MedicineMedicine (R0)